Moximed

Moximed, Inc. was founded in 2008 and primarily develops therapeutic implant devices for the treatment of knee osteoarthritis, aiming to help patients with mild to moderate osteoarthritis protect their knee joints while maintaining a healthy and active lifestyle. The company’s technology, the MISHA™ Knee System, is the result of over a decade of clinical research and development and is the first implantable shock absorber designed to treat medial compartment knee osteoarthritis (OA).